Back to search
FDAFDA · Food and drugs·Recall number D-0869-2016

Avastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901.

Published June 1, 2016 · Recall initiated: January 20, 2015

Summary

FDA records drug Class I recall D-0869-2016, published June 1, 2016 and initiated January 20, 2015. Recalling firm: Pacifico National, Inc. dba AmEx Pharmacy; Status: Terminated; Reported quantity: 45 syringes; Lot: Lot #: 141224C, Exp. 03/24/2015; 150915B, Exp. 12/14/2015. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-Sterility: Product tested positive for bacterial contamination.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pacifico National, Inc. dba AmEx Pharmacy
Distributor
Nationwide
Lot
Lot #: 141224C, Exp. 03/24/2015; 150915B, Exp. 12/14/2015
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Avastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901. recalled?

Yes. FDA published recall D-0869-2016 on June 1, 2016. Reported hazard: Non-Sterility: Product tested positive for bacterial contamination.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit